Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: milestone / Re: lambertslunatics
13
Sep 22, 2009 12:07PM
3
Sep 23, 2009 05:36AM
3
Sep 23, 2009 09:27AM
1
Sep 23, 2009 09:34AM
1
Sep 23, 2009 09:48AM
7
Sep 23, 2009 03:13PM
7
Apr 05, 2010 09:13AM
8
Apr 05, 2010 01:57PM
8
Apr 05, 2010 02:28PM
6
Apr 05, 2010 03:57PM
7
Apr 05, 2010 04:01PM
6
Apr 05, 2010 04:08PM
6
Apr 05, 2010 04:09PM
1
Apr 05, 2010 04:32PM
11
Apr 05, 2010 04:43PM
6
Apr 05, 2010 04:50PM
7
Apr 05, 2010 05:21PM
2
Apr 05, 2010 05:23PM
4
Apr 05, 2010 05:40PM
5
Apr 05, 2010 05:49PM
1
Apr 05, 2010 05:51PM
6
Apr 05, 2010 05:54PM
2
Apr 05, 2010 05:58PM
2
Apr 05, 2010 07:38PM
9
Apr 05, 2010 08:37PM
6
Apr 05, 2010 08:52PM

Hmm....Which of our current BOD members were in their positions when the patents were purchased?

Exemplary logic, indeed! lol

More of your exemplary logic: A message board poster's interpretation of events gleaned from a PR trumps the ongoing due dilligence, stewardship and fiduciary responsibilities of the Board of Directors. And even when 20/20 hindsight repeatedly proves that stewardship ineffective at best, the criticism is due the message board poster, but not the Board of Directors.

Apparently you "stopped to think for a moment...and forgot to start again!".

Consider this milestone phd, how do you think Goerner would have fared with a BOD populated with five well-connected software and IT company executives or other professionals whose skill sets were in line with PTSC's stated core M&A business strategy in control of the BOD rather than a lawyer, an accountant and an anesthesologist. 20/20 hindsight prevents us from knowing this, of course, but so it will for any forseeable future under the guidance of your exemplary logic.

10
Apr 05, 2010 11:10PM
6
Apr 06, 2010 12:25AM
4
Apr 06, 2010 12:32AM
8
Apr 06, 2010 03:32AM
2
Apr 06, 2010 03:04PM
13
Apr 07, 2010 01:17AM
Share
New Message
Please login to post a reply